Literature DB >> 17874869

Pharmaceutical manufacturer prescription assistance programs: are they worth it?

Judy T Chen1, Kent H Summers.   

Abstract

Mesh:

Year:  2007        PMID: 17874869     DOI: 10.18553/jmcp.2007.13.7.611

Source DB:  PubMed          Journal:  J Manag Care Pharm        ISSN: 1083-4087


× No keyword cloud information.
  4 in total

1.  Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication.

Authors:  Walid F Gellad; Haiden A Huskamp; Angela Li; Yuting Zhang; Dana Gelb Safran; Julie M Donohue
Journal:  J Gen Intern Med       Date:  2011-07-13       Impact factor: 5.128

Review 2.  What is the evidence for pharmaceutical patient assistance programs? A systematic review.

Authors:  Tisha M Felder; Nynikka R Palmer; Lincy S Lal; Patricia Dolan Mullen
Journal:  J Health Care Poor Underserved       Date:  2011-02

3.  Medication assistance programs: do all in need benefit equally?

Authors:  Maria Pisu; Katie Crenshaw; Ellen Funkhouser; Midge Ray; Catarina I Kiefe; Kenneth Saag; Cynthia LaCivita; Jeroan J Allison
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

4.  Drug company-sponsored patient assistance programs: a viable safety net?

Authors:  Niteesh K Choudhry; Joy L Lee; Jessica Agnew-Blais; Colleen Corcoran; William H Shrank
Journal:  Health Aff (Millwood)       Date:  2009 May-Jun       Impact factor: 6.301

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.